Last edition
News about "EBITDA growth "
Emcure Reports Robust Q1 FY27 Results, PAT Surges 36 Percent
Emcure Pharmaceuticals reported a strong Q1 FY27 with 22.8 percent revenue growth, 36.2 percent higher profit, improved margins, robust performance across key therapies, and over 15 product approvals in global markets.
EBITDA Growth | 07/08/2026 | By News Bureau | 113
Senores Pharmaceuticals Q1 FY27 Revenue Grows 35.9 Percent YoY to INR 180.2 Crore
Senores Pharmaceuticals reported 35.9 percent Year over Year (YoY) revenue growth to INR 180.2 crore in Q1 FY27, driven by regulated and emerging markets and higher profitability.
EBITDA Growth | 27/07/2026 | By News Bureau | 129
Indegene Achieves Revenue of INR 6,765 Million in First Quarter FY25
Indegene has announced its financial results, achieving revenue of INR 6,765 million in Q1FY25 with growth of 11.4 percent vs Q1FY24.
EBITDA Growth | 02/08/2024 | By Aishwarya | 455
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy